Alternate-day S-1 Oral Therapy for Frail Patients With Metastatic Colorectal and Pancreatic Cancer
In Vivo · 2025
DOI: 10.21873/invivo.14044 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Naoki Odaira und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacotherapy, Faculty of Pharmacy, Niigata University of Pharmacy and Medical and Life Sciences, Niigata, Japan. Hauptthemen laut MEDLINE: Tegafur, Oxonic Acid, Pancreatic Neoplasms, Colorectal Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacotherapy, Faculty of Pharmacy, Niigata University of Pharmacy and Medical and Life Sciences, Niigata, Japan.
- Department of Clinical Pharmacotherapy, Faculty of Pharmacy, Niigata University of Pharmacy and Medical and Life Sciences, Niigata, Japan; kanda@nupals.ac.jp.
- Department of Surgery, Niitsu Medical Center Hospital, Niigata, Japan.
- Division of Oncology Center, Niitsu Medical Center Hospital, Niigata, Japan k.muneoka@niitsu-kenshinkai.com.
Zitieren
APA
Odaira, N., Kanda, J., Sasaki, M., & Muneoka, K. (2025). Alternate-day S-1 Oral Therapy for Frail Patients With Metastatic Colorectal and Pancreatic Cancer. In Vivo. https://doi.org/10.21873/invivo.14044
Vancouver
Odaira N, Kanda J, Sasaki M, Muneoka K. Alternate-day S-1 Oral Therapy for Frail Patients With Metastatic Colorectal and Pancreatic Cancer. In Vivo. 2025. doi:10.21873/invivo.14044
BibTeX
@article{Odaira2025,
author = {Odaira, Naoki and Kanda, Junkichi and Sasaki, Masataka and Muneoka, Katsuki},
title = {Alternate-day S-1 Oral Therapy for Frail Patients With Metastatic Colorectal and Pancreatic Cancer},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.14044}
}
EUVIMED